美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

三倍做多標普生物-Direxion

335.54

+27.218.82%

盤後：335.940.4000+0.12%19:59 EDT

成交量：45.77萬

成交額：1.52億

市值：7.13億

市盈率：- -

高：340.20

開：317.82

低：317.82

收：308.33

52周最高：341.93

52周最低：66.95

股本：212.45萬

流通股本：212.45萬

量比：0.91

換手率：21.54%

股息：1.02

股息率：0.30%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

醫療健康市場動態綜述

遠程醫療公司Hims & Hers在小組會議上敦促FDA擴大某些肽類藥物的獲取途徑後，股價上漲2%。

拉扎德首席執行官表示，銀行家的招聘與晉升重點集中在醫療保健、科技、國防等費用池更大的領域。

醫療保健板塊動態聚焦：市場對話

德康醫療獲選為首家參與FDA數字健康設備試點項目的企業

醫療健康板塊動態聚焦：市場熱議特朗普關税威脅與藥企前景

Candid Health完成由Sixth Street領投的1.2億美元融資

強生(JNJ)旗下OTTAVA™軟組織手術機器人獲FDA批准入局微創手術機器人賽道

醫療保健板塊市場動態綜述

醫療健康板塊動態聚焦：市場熱議

葛蘭旗下中歐醫療健康混合二季報：君實生物(688180.SH)新進十大重倉創新藥及產業鏈仍是佈局主要方向

醫療健康板塊綜述：市場熱議焦點

醫療健康板塊動態：市場熱議聚焦

醫療保健板塊市場動態綜述

美國FDA撤回環孢子蟲疫情中的陽性檢測結果

FDA雖撤回檢測結果，但仍認定泰勒農場生菜與環孢子蟲病疫情有關

环球市场播报

費森尤斯醫療(FMS)推出雲端智能重症透析分析工具TherapyWise™ 已獲FDA認證

FDA確認Taylor Farms生菜樣本環孢子蟲檢測為假陽性

环球市场播报

上海探索醫療健康數據「從資源向價值」轉化新路徑

醫療健康板塊動態聚焦：市場熱議

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/LABU/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多標普生物-Direxion","latestPrice":335.54,"timestamp":1787688000000,"preClose":308.33,"halted":0,"volume":457661,"hourTrading":{"tag":"盘后","latestPrice":335.94,"preClose":335.54,"latestTime":"19:59 EDT","volume":4196,"amount":1407780.9058,"timestamp":1787702372496,"change":0.4,"changeRate":0.001192,"amplitude":0.002801},"delay":0,"changeRate":0.08824960269840768,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"已收盤","change":27.21,"latestTime":"08-25 16:00:00 EDT","open":317.82,"high":340.1999,"low":317.82,"amount":152177225.23880002,"amplitude":0.072584,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":308.33,"sharesOutstanding":3074486,"nav":307.714,"aum":638348472.96,"dividendRate":0.003032,"bidAskSpread":0.003147,"preHourTrading":{"tag":"盘前","latestPrice":320.4,"preClose":308.33,"latestTime":"09:29 EDT","volume":4090,"amount":1297999.7005999999,"timestamp":1787664599999,"change":12.07,"changeRate":0.039146,"amplitude":0.037817},"postHourTrading":{"tag":"盘后","latestPrice":335.94,"preClose":335.54,"latestTime":"19:59 EDT","volume":4196,"amount":1407780.9058,"timestamp":1787702372496,"change":0.4,"changeRate":0.001192,"amplitude":0.002801},"volumeRatio":0.907558,"impliedVol":0.9895,"impliedVolPercentile":0.7928},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.907558,"shares":2124486,"dividePrice":1.0175,"high":340.1999,"amplitude":0.072584,"preClose":308.33,"low":317.82,"week52Low":66.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":335.54,"eps":0,"divideRate":0.003032,"volume":457661,"delay":0,"ttmEps":0,"open":317.82,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":289.98,"twentyDayClose":242,"sixtyDayClose":195.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1107653118","title":"醫療健康市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1107653118","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107653118?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 00:22","pubTimestamp":1784823772,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康板块的市场快讯，现已发布。1007时 —— 罗氏控股首席执行官托马斯·希内克在分析师电话会议中表示，由于公司并无“背水一战”的压力来填补药品管线，其在交易方面采取了非常审慎的态度。受此消息提振，罗氏股价上涨4.4%。去年，FDA曾就奥林巴斯的质量体系要求及合规问题采取行动。杰富瑞维持对该股的“买入”评级，目标价为2300日元。该股目前平盘，报收于1726日元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XLV","LABU","XBI","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653729891","title":"遠程醫療公司Hims & Hers在小組會議上敦促FDA擴大某些肽類藥物的獲取途徑後，股價上漲2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2653729891","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653729891?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 22:32","pubTimestamp":1784817137,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HEAL","BMED","BK4588","LABU","LGHT","FDHT","EKG","GDOC","BK4585","IEIH","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653463742","title":"拉扎德首席執行官表示，銀行家的招聘與晉升重點集中在醫療保健、科技、國防等費用池更大的領域。","url":"https://stock-news.laohu8.com/highlight/detail?id=2653463742","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653463742?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 19:40","pubTimestamp":1784806857,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SHLD","CGVV","LABU","VHT","BK4550","NOBL","XLV","XBI","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191080420","title":"醫療保健板塊動態聚焦：市場對話","url":"https://stock-news.laohu8.com/highlight/detail?id=1191080420","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191080420?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 16:39","pubTimestamp":1784795953,"startTime":"0","endTime":"0","summary":"最新一期覆盖医疗保健板块的《市场对话》栏目发布。罗氏控股第二季度销售额略超预期，但其多项长期增长驱动因素的表现却弱于预期，Intron Health的分析师Naresh Chouhan和Dominic Rose在一份研究报告中指出。分析师表示，许多本应成为增长引擎的药物，如法瑞西单抗、泊洛妥珠单抗、奥妥珠单抗和帕妥珠单抗/曲妥珠单抗复方制剂，均未达预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","XLV","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653515716","title":"德康醫療獲選為首家參與FDA數字健康設備試點項目的企業","url":"https://stock-news.laohu8.com/highlight/detail?id=2653515716","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653515716?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 13:18","pubTimestamp":1784783902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2125909247.SGD","DXCM","BK4548","IE00BMPRXN33.USD","LABU","BK4504","BK4534","BK4585","IE00BMPRXR70.SGD","HEAL","BK4082","LU2433249047.HKD","LU2095319765.USD","BK4588","BK4551","EKG","LU0266013472.USD","GB00BDT5M118.USD","LU0354030511.USD","LU2210149790.SGD","LU2210150020.SGD","LU0354030438.USD","LU2211815571.USD","LU1323610961.USD","LU1923622614.USD","LU2125909593.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111069040","title":"醫療健康板塊動態聚焦：市場熱議特朗普關税威脅與藥企前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1111069040","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111069040?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 00:25","pubTimestamp":1784737510,"startTime":"0","endTime":"0","summary":"在医疗健康板块的最新市场对话中，特朗普总统关于对非美国生产的仿制药征收最高200%关税的威胁，正引发市场对不同药企的差异化评估。对于近期刚刚上市的仿制药企Apotex而言，其前景可能因此陷入困境。特朗普表示，关税将于2028年8月从100%起征，并在一年后上调，此举旨在给予制药商时间转移生产。在中国市场，摩根士丹利预计监管变化将缓和销量增长并损害销售价格，因此下调了对免疫球蛋白和白蛋白收入增长的预测。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU0053666078.USD","LU0528227936.USD","LU0225283273.USD","LU0557290698.USD","IAI","LU0795875086.SGD","LU0912757837.SGD","BK4504","LU1548497426.USD","LU1989772923.USD","XBI","IE00BZ1G4Q59.USD","LU1720051108.HKD","LU2487616109.SGD","BK4581","LU0234570918.USD","LU0106831901.USD","LU1791710582.SGD","LU1064131342.USD","LU2347655156.SGD","LU0390134368.USD","LU1244550221.USD","LU1732800096.USD","LU2271345857.HKD","LU1074936037.SGD","XLV","KBWB","IE00BKVL7J92.USD","LU0158827781.USD","LU0267386448.USD","LU2357305700.SGD","LU1989772840.SGD","LU0210528500.USD","LU1244550577.SGD","LU2089283258.USD","BK4585","BK4127","LU2111349929.HKD","LU0314104364.USD","LU1720051017.SGD","LU0098860793.USD","LU1363072403.SGD","LU0320765646.SGD","LU0882574139.USD","BK4588","LU0795875169.SGD","LU2133065610.SGD","LU1791710400.SGD","LU0971096721.USD","LU1988902786.USD","MS","LU1162221912.USD","BK4534","BK4516","LU1244550494.USD","LU1732799900.SGD","LU2264538146.SGD","LU0158827948.USD","LU2023251221.USD","LU1668664300.SGD","LU2028103732.USD","LU2089284900.SGD","LU0106261372.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653875747","title":"Candid Health完成由Sixth Street領投的1.2億美元融資","url":"https://stock-news.laohu8.com/highlight/detail?id=2653875747","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653875747?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:00","pubTimestamp":1784721638,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["GPZ","AAUM","LABU","VHT","XBI","PRVT","GTPE","PSP","XLV","IXJ","LBO","BK4581","BK4585","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653752268","title":"強生(JNJ)旗下OTTAVA™軟組織手術機器人獲FDA批准 入局微創手術機器人賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2653752268","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653752268?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 19:23","pubTimestamp":1784719387,"startTime":"0","endTime":"0","summary":"强生医疗科技管理层表示，OTTAVA 开辟软组织机器人全新品类，不止是硬件产品迭代，更是推动外科诊疗模式革新。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/ODI2NGE1NjlmODgxZDI1NzFmMmQ4ODQzNDA1OTI5NjU2Mg==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ODI2NGE1NjlmODgxZDI1NzFmMmQ4ODQzNDA1OTI5NjU2Mg==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302889","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","IE0009355771.USD","LU0320765646.SGD","LU0072461881.USD","LU0124676726.USD","RXL","IE000SO60NU8.SGD","FTXH","BK4007","LU0795875086.SGD","LU1228905540.USD","IYH","LABU","JNJ","LU1674673428.USD","LU0070217475.USD","BK4568","LU0640476718.USD","LU2505996681.GBP","PJP","BK4581","HTEC","LU0234572021.USD","LU1929549753.HKD","IE00BJJMRZ35.SGD","VHT","IE00BVYPNV92.GBP","GDOC","LU0432979614.USD","LU1059921491.USD","LU2750360997.AUD","MDEV","MEDX","IE000M9KFDE8.USD","BMED","TRUH","BK4588","LU0203347892.USD","LU2133065610.SGD","XLV","BK4592","FHLC","LU0345769631.USD","LU1430594728.SGD","IXJ","LU1778281490.HKD","LU0985320562.USD","LU0964807845.USD","IHE","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138810904","title":"醫療保健板塊市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1138810904","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138810904?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 04:56","pubTimestamp":1784667408,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场对话。0814 ET - 丹纳赫正释放出近期内生增长放缓的信号，预计第三季度核心营收仅将温和增长2%至3%。该股在盘前交易中下跌超过11%，报178.55美元。0402 ET - 摩根大通分析师在一份研究报告中指出，诺华第二季度业绩优于预期，并重申全年指引，这意味着市场对这家瑞士制药商核心盈利的普遍预期存在上调空间。Canaccord Genuity 将瑞思迈在澳大利亚证券交易所上市股票的目标价下调10%，至40.00澳元。该股下跌0.5%，报28.05澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGLO","VOTE","VGFPF","DECU","BK4588","JOYT","LABU","PMDE","XLV","GXDW","FEBU","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174901927","title":"醫療健康板塊動態聚焦：市場熱議","url":"https://stock-news.laohu8.com/highlight/detail?id=1174901927","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174901927?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 00:25","pubTimestamp":1784651155,"startTime":"0","endTime":"0","summary":"在医疗健康领域，最新市场讨论聚焦于多家关键企业的业绩与战略动向。尽管如此，市场反应消极，其股价在盘前交易中下跌超过11%，报178.55美元。诺华制药方面，其第二季度业绩表现超出预期，并重申了全年指引，这为市场共识预期的上调留下了空间。然而，对于诺华强劲的第二季度业绩，市场分析也呈现出不同的视角。另一方面，呼吸技术供应商瑞思迈的动向也备受关注。Canaccord Genuity将其对瑞思迈在澳交所上市股票的目标价下调10%，至40澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GXDW","VOTE","PMDE","DECU","BK4581","XBI","RGLO","VGFPF","BK4585","XLV","JOYT","BK4588","FEBU","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653733442","title":"葛蘭旗下中歐醫療健康混合二季報：君實生物(688180.SH)新進十大重倉 創新藥及產業鏈仍是佈局主要方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2653733442","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653733442?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 17:16","pubTimestamp":1784625396,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，7月21日，中欧基金披露葛兰和赵磊共同管理的中欧医疗健康混合型证券投资基金2026年第2季度报告。此外，君实生物新进持仓前十，信立泰跌出十大重仓。葛兰在季报中指出，2026年第二季度，市场风格分化显著，医药生物板块经历大幅震荡，整体走势弱于大盘。葛兰表示，第三季度创新药及产业链仍是布局的主要方向。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01877","BK4585","BK1583","LABU","BK1161","MEDX","BK4550","688180","XLV","LNGR","BK4588","159992","BK0239","06978","IXJ","BK4581","VHT","IBBQ","159760","XBI","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197006151","title":"醫療健康板塊綜述：市場熱議焦點","url":"https://stock-news.laohu8.com/highlight/detail?id=1197006151","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197006151?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 16:24","pubTimestamp":1784622261,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康板块的市场热议已发布。诺华公司第二季度业绩超出预期，并重申了全年指引，摩根大通分析师在一份研究报告中指出，这意味着市场对这家瑞士制药巨头核心盈利的共识预期存在上调空间。分析师表示，该公司第二季度核心每股收益为2.41美元，超出市场普遍预期12%。诺华仍预计今年核心营业利润将录得低个位数百分比下降。该股目前上涨2.1%。多肽集团股价上涨4.8%，至43.75瑞士法郎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","XLV","LABU","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133126886","title":"醫療健康板塊動態：市場熱議聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1133126886","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133126886?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 04:53","pubTimestamp":1784580803,"startTime":"0","endTime":"0","summary":"最新一期关于医疗健康板块的市场热议。欧洲商会警告贸易战风险。美国于六月宣布将调查德国政府削减药品支出的计划。他强调，欧盟应坚持要求遵守去年达成的欧美贸易协议。股价上涨0.7%，至765印尼盾。诺和诺德全年指引成焦点。GSK新药试验结果令人失望。杰富瑞对Ramsay Health Care的增持评级，基于对其澳大利亚私立医院业务预期改善的判断。这包括市场份额的扩大和手术组合的增加。该机构维持对Ramsay每股45.20澳元的目标价，该股上周收于43.12澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","XLV","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159771526","title":"醫療保健板塊市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1159771526","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159771526?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 00:23","pubTimestamp":1784564589,"startTime":"0","endTime":"0","summary":"跨大西洋贸易紧张局势持续，德国工商总会贸易主管福尔克·特雷尔表示，这强化了欧盟必须拒绝美国就药品定价对德国进行调查的立场。美国于六月宣布将调查德国政府削减药品支出的计划。他强调，欧盟应坚持遵守去年达成的欧美贸易协议。特雷尔还提到，欧盟也不应忘记其长期目标，即取消与世界贸易组织规则不符的美国关税。杰登证券对Ramsay Health Care的增持评级，基于对其澳大利亚私立医院业务预期改善的看好，包括市场份额扩大和手术组合优化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4585","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653212215","title":"美國FDA撤回環孢子蟲疫情中的陽性檢測結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2653212215","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653212215?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 00:01","pubTimestamp":1784563265,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652140852","title":"FDA雖撤回檢測結果，但仍認定泰勒農場生菜與環孢子蟲病疫情有關","url":"https://stock-news.laohu8.com/highlight/detail?id=2652140852","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652140852?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 23:02","pubTimestamp":1784559720,"startTime":"0","endTime":"0","summary":"美国食品和药物管理局周日表示，此前一项实验室检测曾显示泰勒农场墨西哥分公司供应的碎冰山生菜样本受到环孢子虫污染，但该结果实为假阳性。　　不过，FDA并未因此撤回其原有结论。该机构的溯源调查仍表明，这家公司与一起波及多州的环孢子虫病疫情存在关联。　　FDA表示，实验室专家重新分析了该样本，认定最初的检测结果“并非真正的扩增，应视为假阳性”。该机构同时指出，目前尚无任何产品样本被确认为环孢子虫阳性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/world/2026-07-20/doc-iniinmvv2922082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652255215","title":"費森尤斯醫療(FMS)推出雲端智能重症透析分析工具TherapyWise™ 已獲FDA認證","url":"https://stock-news.laohu8.com/highlight/detail?id=2652255215","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652255215?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 20:56","pubTimestamp":1784552176,"startTime":"0","endTime":"0","summary":"金吾财讯 | 全球透析龙头费森尤斯医疗 正式发布云端智能分析系统 TherapyWise，该功能集成于已获美国 FDA 510  认证的 NxView 4.0 软件平台，适配 NxStage System One 设备，面向美国医院急症、ICU 重症肾脏替代治疗场景使用。据悉，产品属于费森尤斯重症护理数字化矩阵，依托云端数据加密传输体系，兼顾临床数据安全与多院区统一管理需求。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/MzQxYTIyYmRmODZkZWYzMTgwODQwNjkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MzQxYTIyYmRmODZkZWYzMTgwODQwNjkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302771","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMS","BK4588","BK4585","LABU","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652215926","title":"FDA確認Taylor Farms生菜樣本環孢子蟲檢測為假陽性","url":"https://stock-news.laohu8.com/highlight/detail?id=2652215926","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652215926?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 20:40","pubTimestamp":1784551200,"startTime":"0","endTime":"0","summary":"美国食品和药物管理局7月19日确认，此前对Taylor Farms生菜样本的环孢子虫检测结果为假阳性。由于环孢子虫检测过程复杂，实验室专家重新审核样本后认定该结果不代表真实阳性反应。　　此次环孢子虫病疫情自5月以来已波及全美34个州。　　Taylor Farms上周五宣布主动召回源自墨西哥中部地区的所有冰山生菜。　　FDA明确表示调查仍在继续。Taco Bell表示已从全美门店供应链中移除受影响的Taylor Farms生菜。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-20/doc-iniinfqe5044943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652975332","title":"上海探索醫療健康數據「從資源向價值」轉化新路徑","url":"https://stock-news.laohu8.com/highlight/detail?id=2652975332","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652975332?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 18:32","pubTimestamp":1784543526,"startTime":"0","endTime":"0","summary":"7月18日召开的2026世界人工智能大会（WAIC）生命健康专区“AI驱动生命健康产业全链条革新”系列活动传出消息：当前，以大模型、多模态人工智能、智能体和高性能算力为代表的新一代人工智能技术正在加速融入生命健康领域。与会专家认为，人工智能正在推动生命健康产业由单点应用向全链条协同发展迈进。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607203813432516.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607203813432516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4550","BK4581","IXJ","VHT","XBI","159760","BK4585","XLV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105805641","title":"醫療健康板塊動態聚焦：市場熱議","url":"https://stock-news.laohu8.com/highlight/detail?id=1105805641","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105805641?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 16:23","pubTimestamp":1784535835,"startTime":"0","endTime":"0","summary":"医疗健康领域的最新市场观点在此汇集。此外，约占其销售成本15%的与油价相关的活性药物成分成本上涨约30%，其影响预计将在第三季度开始显现，进一步加剧利润率压力。花旗认为，市场已普遍预期并消化了指引上调的可能性。Jarden对Ramsay Health Care的增持评级，基于对其澳大利亚私立医院业务预期改善的判断。这包括市场份额的扩大和手术组合的优化。分析师Steve Wheen还预计，随着达成覆盖工资通胀的私人健康保险协议，Ramsay将提高产能利用率并小幅扩大利润率。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XBI","BK4581","LABU","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}